177 related articles for article (PubMed ID: 27612308)
1. Activity-Based Probes for 15-Lipoxygenase-1.
Eleftheriadis N; Thee SA; Zwinderman MR; Leus NG; Dekker FJ
Angew Chem Int Ed Engl; 2016 Sep; 55(40):12300-5. PubMed ID: 27612308
[TBL] [Abstract][Full Text] [Related]
2. Identification of 6-benzyloxysalicylates as a novel class of inhibitors of 15-lipoxygenase-1.
Eleftheriadis N; Thee S; te Biesebeek J; van der Wouden P; Baas BJ; Dekker FJ
Eur J Med Chem; 2015 Apr; 94():265-75. PubMed ID: 25771032
[TBL] [Abstract][Full Text] [Related]
3. Human 15-LOX-1 active site mutations alter inhibitor binding and decrease potency.
Armstrong M; van Hoorebeke C; Horn T; Deschamps J; Freedman JC; Kalyanaraman C; Jacobson MP; Holman T
Bioorg Med Chem; 2016 Nov; 24(21):5380-5387. PubMed ID: 27647374
[TBL] [Abstract][Full Text] [Related]
4. A high throughput screen identifies potent and selective inhibitors to human epithelial 15-lipoxygenase-2.
Jameson JB; Kantz A; Schultz L; Kalyanaraman C; Jacobson MP; Maloney DJ; Jadhav A; Simeonov A; Holman TR
PLoS One; 2014; 9(8):e104094. PubMed ID: 25111178
[TBL] [Abstract][Full Text] [Related]
5. Rational Development of a Potent 15-Lipoxygenase-1 Inhibitor with in Vitro and ex Vivo Anti-inflammatory Properties.
Eleftheriadis N; Neochoritis CG; Leus NG; van der Wouden PE; Dömling A; Dekker FJ
J Med Chem; 2015 Oct; 58(19):7850-62. PubMed ID: 26331552
[TBL] [Abstract][Full Text] [Related]
6.
Golovanov A; Zhuravlev A; Cruz A; Aksenov V; Shafiullina R; Kakularam KR; Lluch JM; Kuhn H; González-Lafont À; Ivanov I
J Med Chem; 2022 Feb; 65(3):1979-1995. PubMed ID: 35073698
[TBL] [Abstract][Full Text] [Related]
7. Substituted (E)-2-(2-benzylidenehydrazinyl)-4-methylthiazole-5-carboxylates as dual inhibitors of 15-lipoxygenase & carbonic anhydrase II: synthesis, biochemical evaluation and docking studies.
Saeed A; Khan SU; Mahesar PA; Channar PA; Shabir G; Iqbal J
Biochem Biophys Res Commun; 2017 Jan; 482(1):176-181. PubMed ID: 27836541
[TBL] [Abstract][Full Text] [Related]
8. Identification of amino acid determinants of the positional specificity of mouse 8S-lipoxygenase and human 15S-lipoxygenase-2.
Jisaka M; Kim RB; Boeglin WE; Brash AR
J Biol Chem; 2000 Jan; 275(2):1287-93. PubMed ID: 10625675
[TBL] [Abstract][Full Text] [Related]
9. The structure of human 15-lipoxygenase-2 with a substrate mimic.
Kobe MJ; Neau DB; Mitchell CE; Bartlett SG; Newcomer ME
J Biol Chem; 2014 Mar; 289(12):8562-9. PubMed ID: 24497644
[TBL] [Abstract][Full Text] [Related]
10. Discovery of natural 15-LOX small molecule inhibitors from Chinese herbal medicine using virtual Screening, biological evaluation and molecular dynamics studies.
Li Y; Zhang Y; Wu X; Gao Y; Guo J; Tian Y; Lin Z; Wang X
Bioorg Chem; 2021 Oct; 115():105197. PubMed ID: 34426159
[TBL] [Abstract][Full Text] [Related]
11. Identification of NSAIDs as lipoxygenase inhibitors through highly sensitive chemiluminescence method, expression analysis in mononuclear cells and computational studies.
Shahid W; Ejaz SA; Al-Rashida M; Saleem M; Ahmed M; Rahman J; Riaz N; Ashraf M
Bioorg Chem; 2021 May; 110():104818. PubMed ID: 33784531
[TBL] [Abstract][Full Text] [Related]
12. Molecular mechanism of 15-lipoxygenase allosteric activation and inhibition.
Meng H; Dai Z; Zhang W; Liu Y; Lai L
Phys Chem Chem Phys; 2018 May; 20(21):14785-14795. PubMed ID: 29780994
[TBL] [Abstract][Full Text] [Related]
13. A potent and selective inhibitor targeting human and murine 12/15-LOX.
Armstrong MM; Freedman CJ; Jung JE; Zheng Y; Kalyanaraman C; Jacobson MP; Simeonov A; Maloney DJ; van Leyen K; Jadhav A; Holman TR
Bioorg Med Chem; 2016 Mar; 24(6):1183-90. PubMed ID: 26899595
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of key enzymes in the inflammatory pathway by hybrid molecules of terpenes and synthetic drugs: In vitro and in silico studies.
Theoduloz C; Alzate-Morales J; Jiménez-Aspee F; Isla MI; Alberto MR; Pertino MW; Schmeda-Hirschmann G
Chem Biol Drug Des; 2019 Mar; 93(3):290-299. PubMed ID: 30294891
[TBL] [Abstract][Full Text] [Related]
15. Novel 1,2,4-triazine-quinoline hybrids: The privileged scaffolds as potent multi-target inhibitors of LPS-induced inflammatory response via dual COX-2 and 15-LOX inhibition.
Ghanim AM; Rezq S; Ibrahim TS; Romero DG; Kothayer H
Eur J Med Chem; 2021 Jul; 219():113457. PubMed ID: 33892270
[TBL] [Abstract][Full Text] [Related]
16. A combinatorial approach for the discovery of drug-like inhibitors of 15-lipoxygenase-1.
van der Vlag R; Guo H; Hapko U; Eleftheriadis N; Monjas L; Dekker FJ; Hirsch AKH
Eur J Med Chem; 2019 Jul; 174():45-55. PubMed ID: 31026746
[TBL] [Abstract][Full Text] [Related]
17. In vitro study of isoflavones and isoflavans as potent inhibitors of human 12- and 15-lipoxygenases.
Mascayano C; Espinosa V; Sepúlveda-Boza S; Hoobler EK; Perry S
Chem Biol Drug Des; 2013 Sep; 82(3):317-25. PubMed ID: 23663316
[TBL] [Abstract][Full Text] [Related]
18. Novel 15-Lipoxygenase-1 Inhibitor Protects Macrophages from Lipopolysaccharide-Induced Cytotoxicity.
Guo H; Verhoek IC; Prins GGH; van der Vlag R; van der Wouden PE; van Merkerk R; Quax WJ; Olinga P; Hirsch AKH; Dekker FJ
J Med Chem; 2019 May; 62(9):4624-4637. PubMed ID: 30964295
[TBL] [Abstract][Full Text] [Related]
19. Identification of a Bromodomain-like Region in 15-Lipoxygenase-1 Explains Its Nuclear Localization.
Chen D; Xiao Z; Guo H; Gogishvili D; Setroikromo R; van der Wouden PE; Dekker FJ
Angew Chem Int Ed Engl; 2021 Sep; 60(40):21875-21883. PubMed ID: 34388301
[TBL] [Abstract][Full Text] [Related]
20. O-prenylated 3-carboxycoumarins as a novel class of 15-LOX-1 inhibitors.
Jabbari A; Mousavian M; Seyedi SM; Bakavoli M; Sadeghian H
PLoS One; 2017; 12(2):e0171789. PubMed ID: 28182779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
